PEG/RGD-modified magnetic polymeric liposomes for controlled drug release and tumor cell targeting

PEG/RGD-modified magnetic polymeric liposomes for controlled drug release and tumor cell targeting Article history: Polymeric liposomes (PEG/RGD-MPLs), composed of amphiphilic polymer octadecyl-quaternized mod- Received 9 October 2011 ified poly (-glutamic acid) (OQPGA), PEGylated OQPGA, RGD peptide grafted OQPGA and magnetic Received in revised form nanoparticles, was prepared successfully. These PEG/RGD-MPLs could be used as a multifunctional plat- 15 December 2011 form for targeted drug delivery. The results showed that PEG/RGD-MPLs were multilamellar spheres with Accepted 7 January 2012 nano-size (50–70 nm) and positive surface charge (28–42 mV). Compared with magnetic conventional Available online 14 January 2012 liposomes (MCLs), PEG/RGD-MPLs exhibited sufficient size and zeta potential stability, low initial burst release and less magnetic nanoparticles leakage. The cell uptake results suggested that the PEG/RGD- Keywords: MPLs (with RGD and magnetic particles) exhibited more drug cellular uptake than non RGD and non Drug delivery magnetism carriers in MCF-7 cells. MTT assay revealed that PEG/RGD-MPLs showed lower in vitro cyto- Polymeric liposomes toxicity to GES-1 cells at ≤100 g/mL. These data indicated that the multifunctional PEG/RGD-MPLs may Magnetic nanoparticles Tumor Targeting be an alternative formulation for drug delivery system. RGD peptide © 2012 Elsevier B.V. All rights reserved. 1. Introduction as drug carriers, MDT can guide their accumulation in target tis- sues under strong http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png International Journal of Pharmaceutics Elsevier

PEG/RGD-modified magnetic polymeric liposomes for controlled drug release and tumor cell targeting

Loading next page...
 
/lp/elsevier/peg-rgd-modified-magnetic-polymeric-liposomes-for-controlled-drug-Jirh3QvaH3
Publisher
Elsevier
Copyright
Copyright © 2012 Elsevier B.V.
ISSN
0378-5173
D.O.I.
10.1016/j.ijpharm.2012.01.013
Publisher site
See Article on Publisher Site

Abstract

Article history: Polymeric liposomes (PEG/RGD-MPLs), composed of amphiphilic polymer octadecyl-quaternized mod- Received 9 October 2011 ified poly (-glutamic acid) (OQPGA), PEGylated OQPGA, RGD peptide grafted OQPGA and magnetic Received in revised form nanoparticles, was prepared successfully. These PEG/RGD-MPLs could be used as a multifunctional plat- 15 December 2011 form for targeted drug delivery. The results showed that PEG/RGD-MPLs were multilamellar spheres with Accepted 7 January 2012 nano-size (50–70 nm) and positive surface charge (28–42 mV). Compared with magnetic conventional Available online 14 January 2012 liposomes (MCLs), PEG/RGD-MPLs exhibited sufficient size and zeta potential stability, low initial burst release and less magnetic nanoparticles leakage. The cell uptake results suggested that the PEG/RGD- Keywords: MPLs (with RGD and magnetic particles) exhibited more drug cellular uptake than non RGD and non Drug delivery magnetism carriers in MCF-7 cells. MTT assay revealed that PEG/RGD-MPLs showed lower in vitro cyto- Polymeric liposomes toxicity to GES-1 cells at ≤100 g/mL. These data indicated that the multifunctional PEG/RGD-MPLs may Magnetic nanoparticles Tumor Targeting be an alternative formulation for drug delivery system. RGD peptide © 2012 Elsevier B.V. All rights reserved. 1. Introduction as drug carriers, MDT can guide their accumulation in target tis- sues under strong

Journal

International Journal of PharmaceuticsElsevier

Published: Apr 15, 2012

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off